All blog posts
Total 27 results for
Showing 12 out of 27 results
08 December 2020
As the Bundestag passes the legislation to ratify the UPC Agreement, the UPC may finally open its doors in 2022
26 November 2020
The European Commission considers the future of health in Europe with new Pharmaceutical Strategy and Action Plan on IP
11 September 2020
The Unified Patent Court - on the move again?
17 August 2020
Patent and Pharma Update, August 2020
21 July 2020
UK's exit from the UPC now final
09 July 2020
The CJEU’s decision in Santen confirms a restrictive interpretation of ‘product’ under article 1(b) and 3(d) of the SPC Regulation, and rejects the possibility of an SPC based on a Marketing Authorisation for a new use of a previously authorised product
21 May 2020
Pepper trumps Broccoli: EPO finds products produced by essentially biological processes are not patentable
18 May 2020
COVID-19: PRESSURE POINTS: Developments at Patent Courts in Europe in light of the health emergency (UK, Germany, France, Italy & the EPO)
13 May 2020
Tech Disputes webinar series (Episode 1: FRAND 2.0 – licensing in a world of new standards)
12 May 2020
Patent and Pharma Update, May 2020
30 April 2020
COVID-19: Pressure Points: Supply Chain Difficulties – new global guide, including IP, advertising and collaboration issues
22 April 2020
The UK will not participate in the UPC confirms IP Minister responding to House of Lords' letter
Showing 12 out of 27 results
View moreKey contacts
Rebekah Gay
Partner, Head of Intellectual Property, Sydney
Laura Orlando
Managing Partner, Milan Office, Milan
Sue Gilchrist
Consultant, Sydney
Peng Lei
Partner, Herbert Smith Freehills Kramer Kewei Joint Operation, Mainland China and Shanghai
Alexandra Neri
Partner, Paris
Dr Ina vom Feld
Partner, Germany
Sebastian Moore
Partner, Head Intellectual Property, London and Milan
Rachel Montagnon
Knowledge Counsel, London